AtriCure (ATRC)
AtriCure Price: 8.99
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ATRC Price Rankings
| Overall | 31st percentile | 5300 of 7690 |
| Sector | 56th percentile | 247 of 574 in Healthcare |
| Industry | 45th percentile | 38 of 70 in Medical Instruments & Supplies |
ATRC Price Range, Past 5 Years
| Minimum | 1.07 | Apr 24 2009 |
| Maximum | 14.50 | Jun 2 2011 |
| Average | 8.305 |
About Price
The price of one share of stock, which is set by the market. Share price can be used to find a company's total market value, as represented by market capitalization.
Learn More
You may also be interested in these ATRC related companies
ATRC News
Listen to $ATRC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eG8
about 24 days ago by earningscast
about 24 days ago by earningscast
$ATRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kwl
about 44 days ago by MarketBrief
about 44 days ago by MarketBrief
Leerink Swann Starts AtriCure Inc. (ATRC) at Outperform; Positive Sales Growth Inflection Point
Mar 20, 7:14AM Street Insider
Mar 20, 7:14AM Street Insider
Listen to $ATRC Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2a3D
about 90 days ago by earningscast
about 90 days ago by earningscast
AtriCure to Announce Fourth Quarter and Full Year 2011 Financial Results
Feb 21, 3:00PM Business Wire
Feb 21, 3:00PM Business Wire
Canaccord Genuity Reiterates a 'Buy' on AtriCure (ATRC); ATRC Has Productive STS
Feb 02, 9:36AM Street Insider
Feb 02, 9:36AM Street Insider
$ATRC Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
about 163 days ago by Benzinga
about 163 days ago by Benzinga
Listen to $ATRC at piper jaffray health care conference - live at 10:00 AM, ondemand after - http://stks.co/1Jy5
about 179 days ago by earningscast
about 179 days ago by earningscast
$ATRC up 24.2%. Panel Recommends FDA Approval for Atrial Fibrillation Treatment
about 213 days ago by lewisgreen
about 213 days ago by lewisgreen
Great news for cheaper and less invasive treatment from $ATRC : http://on.wsj.com/oMFNyI
about 326 days ago by Mdhemp
about 326 days ago by Mdhemp
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATRC | 8.99 | +0.58 | +6.90% | 148.16M |
| ARTC | 26.44 | +0.93 | +3.65% | 729.48M |
| ART | 3.02 | +0.01 | +0.33% | 176.01M |
| ARSD | 10.12 | -0.18 | -1.75% | 240.25M |
| ARRY | 3.46 | -0.19 | -5.21% | 282.16M |
| ARRS | 12.32 | -0.01 | -0.08% | 1.418B |
| ARR | 6.95 | +0.05 | +0.72% | 984.88M |
| ARQL | 5.87 | +0.05 | +0.86% | 316.69M |
| AROW | 23.85 | -0.05 | -0.21% | 283.82M |
| ARO | 19.19 | +0.17 | +0.89% | 1.554B |
